$3.06
▼ -1.9% Today
as of Jul 22, 16:48 ET
Last 30 days
Recent Press Releases & News
Elicio Therapeutics Closes $15 Million Registered Direct Offering
Elicio Therapeutics Announces Closing of $15 Million Registered Direct Offering
Another Blow For ELTX? Elicio Raises Fresh Capital Weeks After Trial Disappointment
Overview
52-week range
$7.37
$15
0% of range
Avg surprise (last 3)
-19.4%
Avg reaction (last 2)
+10.3%
100% positive
Latest IV / EM
119%
EM ±27.2% · $3 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Mon May 11, 2026 | Mar/2026 | $-0.65 | $-0.49 | -32.6% | +25.3% | +17.2% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.60 | — | — | — | — | financials |
| Thu Aug 7, 2025 | Jun/2025 | $-0.66 | $-0.69 | +4.3% | — | — | earnings |
| Tue May 13, 2025 | Mar/2025 | $-0.87 | $-0.67 | -29.9% | — | +3.4% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-1.39 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.64 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-1.15 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-1.27 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-2.61 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Aug 6, 2026 | Jun/2026 | OTHER | -$0.53 | -$0.66 | +19.7% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-11M | — | $-8M | $-10M | $-11M | — | $-10M | $-11M |
| Net income | $-12M | — | $-10M | $-11M | $-11M | — | $-19M | $-7M |
| EPS (diluted) | $-0.65 | — | $-0.60 | $-0.66 | $-0.87 | — | $-1.39 | $-0.64 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $15M | $19M | $21M | $22M | $18M | $18M | $26M | $3M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $16M | $19M | $21M | $23M | $21M | $21M | $31M | $7M |
| Total assets | $23M | $26M | $28M | $30M | $28M | $28M | $38M | $16M |
| Long-term debt | $9M | $9M | $10M | $9M | — | $20M | — | — |
| Total liabilities | $24M | $24M | $24M | $28M | $19M | $39M | $57M | $17M |
| Total equity | $-1M | $2M | $4M | $2M | $9M | $-11M | $-19M | $-2M |